Tomo Nozawa Selected Research

Sacroiliac Arthritis

1/2013

2 cases of HLA-B27-positive seronegative spondylarthritides in pediatric age treated with adalimumab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tomo Nozawa Research Topics

Disease

5	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 06/2022 - 01/2013
4	Cryopyrin-Associated Periodic Syndromes 01/2024 - 01/2012
4	Arthritis (Polyarthritis) 01/2023 - 01/2015
4	Inflammation (Inflammations) 01/2015 - 01/2012
3	Infections 05/2019 - 01/2012
3	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2018 - 04/2012
3	Fever (Fevers) 01/2015 - 01/2012
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2024 - 01/2015
2	Aneurysm (Aneurysms) 11/2017 - 04/2012
2	Rheumatic Diseases (Rheumatism) 05/2016 - 01/2012
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 03/2015 - 01/2015
1	Wounds and Injuries (Trauma) 02/2021
1	Disease Progression 05/2019
1	Chickenpox 05/2019
1	Tuberculosis (Tuberculoses) 05/2016
1	Lupus Nephritis 03/2015
1	Muscular Diseases (Myopathy) 05/2014
1	Neoplasms (Cancer) 01/2014
1	Leukemia 01/2014
1	Macrophage Activation Syndrome 01/2014
1	Leukocytosis (Pleocytosis) 01/2014
1	Drug-Related Side Effects and Adverse Reactions 05/2013
1	Sacroiliac Arthritis 01/2013
1	Spondylitis 01/2013
1	Neck Pain (Cervicalgia) 01/2013
1	Polymyositis 01/2013
1	Pain (Aches) 01/2013
1	Arthralgia (Joint Pain) 01/2013
1	Spondylarthritis (Spinal Arthritis) 01/2013
1	Axial Spondyloarthritis 01/2013
1	Communicable Diseases (Infectious Diseases) 01/2012
1	Disseminated Intravascular Coagulation 01/2012
1	Gastroenteritis 01/2012
1	Nasopharyngitis 01/2012
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2012
1	Pyoderma Gangrenosum 12/2008

Drug/Important Bio-Agent (IBA)

5	tocilizumab (atlizumab)FDA Link 05/2019 - 01/2013
4	canakinumab FDA Link 01/2024 - 01/2012
4	Infliximab (Remicade)FDA Link 01/2018 - 12/2008
3	C-Reactive ProteinIBA 01/2023 - 04/2012
3	CytokinesIBA 01/2015 - 01/2012
3	SteroidsIBA 01/2014 - 01/2012
2	InterleukinsIBA 01/2024 - 05/2013
2	Interleukin-18 (Interleukin 18)IBA 06/2022 - 05/2019
2	Methotrexate (Mexate)FDA LinkGeneric 02/2021 - 01/2014
2	Interleukin-6 (Interleukin 6)IBA 05/2019 - 01/2014
2	Immunosuppressive Agents (Immunosuppressants)IBA 05/2016 - 01/2013
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 03/2015 - 01/2015
2	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2015 - 12/2008
2	Monoclonal AntibodiesIBA 01/2015 - 12/2008
2	AntibodiesIBA 05/2014 - 01/2014
2	Methylprednisolone FDA LinkGeneric 05/2014 - 01/2014
2	Ferritins (Ferritin)IBA 01/2014 - 01/2012
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2012 - 12/2008
1	Interleukin-1 (Interleukin 1)IBA 01/2024
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	p38 Mitogen-Activated Protein KinasesIBA 06/2022
1	GlucocorticoidsIBA 02/2021
1	Analgesics (Analgesic Drugs)IBA 02/2021
1	Prednisone (Sone)FDA LinkGeneric 02/2021
1	GoldIBA 05/2016
1	InterferonsIBA 05/2016
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2014
1	Signal Recognition ParticleIBA 05/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2014
1	fibrin fragment D (D-dimer)IBA 01/2014
1	Pyrin Domain-Containing 3 Protein NLR FamilyIBA 05/2013
1	Fructose-Bisphosphate Aldolase (Aldolase)IBA 01/2013
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2013
1	Adalimumab (Humira)FDA Link 01/2013
1	Intravenous Immunoglobulins (IVIG)FDA Link 04/2012
1	PalmitatesIBA 01/2012
1	Antiviral Agents (Antivirals)IBA 01/2012
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2012
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2012
1	Immunologic Factors (Immunomodulators)IBA 01/2012
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2012
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2008
1	Prednisolone (Predate)FDA LinkGeneric 12/2008

Therapy/Procedure

8	Therapeutics 05/2019 - 04/2012
1	Plasma Exchange 05/2014